Athos is an investment firm focused on entrepreneurially and value-based investing, with a specialization in Pharma and Life Science. It targets technology-driven companies and real estate, operating primarily in the European market as indicated by its German web presence. The firm emphasizes value-based investing and partnerships with companies in the pharmaceutical and life sciences sectors. Headquartered or active in a German-speaking region, Athos presents itself as a niche investor within biotech, pharma, and related healthcare fields.